Lars Fruergaard Jorgensen, the chief executive of once-highflying Danish drugmaker Novo Nordisk, is stepping down after eight years in the role, the maker of Ozempic and Wegovy drugs announced on ...

Ozempic and Mounjaro, originally diabetes medications, have exploded in popularity as powerful weight-loss injectables.